KAYLIN GARNETT: Open Payments
NPI 1609396324 · AUBURN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,304 in 126 payments from 18 companies in 2025. Trend: 2023 $2,129 · 2024 $2,128 · 2025 $2,304
Food & beverage: $2,023Education: $281
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $468 |
| ABBVIE INC. | 44 | $446 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $292 |
| Novartis Pharmaceuticals Corporation | 9 | $224 |
| Regeneron Healthcare Solutions, Inc. | 9 | $182 |
| Organon LLC | 4 | $158 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $72 |
| PFIZER INC. | 4 | $66 |
| Amgen Inc. | 3 | $63 |
Products named: TREMFYA, RINVOQ, DUPIXENT, VTAMA, SKYRIZI, Winlevi, ILUMYA, CIBINQO.
Industry payments across AL — which companies pay providers there.
